Welcome to LookChem.com Sign In|Join Free

CAS

  • or

114095-04-4

Post Buying Request

114095-04-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

114095-04-4 Usage

Description

Imidazo[2,1-b]benzothiazole-2-carboxaldehyde is a versatile chemical compound belonging to the imidazole family, characterized by the presence of a benzothiazole ring. It is renowned for its diverse biological and chemical properties, which include antimicrobial, antifungal, and anticancer activities. This makes it a valuable building block in the synthesis of pharmaceuticals, agrochemicals, and dyes, and has garnered significant interest in medicinal chemistry and chemical biology for its potential applications.

Uses

Used in Pharmaceutical Industry:
Imidazo[2,1-b]benzothiazole-2-carboxaldehyde is used as a key intermediate in the synthesis of various therapeutic agents due to its biological activities. Its antimicrobial, antifungal, and anticancer properties make it a promising candidate for the development of new drugs to combat infections and cancer.
Used in Agrochemical Industry:
In the agrochemical sector, Imidazo[2,1-b]benzothiazole-2-carboxaldehyde is utilized as a component in the creation of pesticides and other agrochemicals, leveraging its antimicrobial and antifungal properties to protect crops and enhance agricultural productivity.
Used in Dye Industry:
Imidazo[2,1-b]benzothiazole-2-carboxaldehyde is also employed in the synthesis of dyes, where its chemical properties contribute to the development of novel colorants for various applications, including textiles and other industrial uses.
Used as a Fluorescent Probe:
Imidazo[2,1-b]benzothiazole-2-carboxaldehyde is used as a fluorescent probe for detecting metal ions, capitalizing on its ability to interact with these ions and provide a visual or measurable response, which is crucial in chemical analysis and environmental monitoring.
Used as an Enzyme Inhibitor:
Furthermore, it serves as an enzyme inhibitor, where its interaction with specific enzymes can modulate biological processes, offering potential therapeutic benefits in the treatment of various diseases by controlling enzyme activity.
Overall, Imidazo[2,1-b]benzothiazole-2-carboxaldehyde's multifaceted applications across different industries underscore its importance and potential in chemical and biological research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 114095-04-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,0,9 and 5 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 114095-04:
(8*1)+(7*1)+(6*4)+(5*0)+(4*9)+(3*5)+(2*0)+(1*4)=94
94 % 10 = 4
So 114095-04-4 is a valid CAS Registry Number.

114095-04-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name imidazo[2,1-b][1,3]benzothiazole-2-carbaldehyde

1.2 Other means of identification

Product number -
Other names IMIDAZO[2,1-B]BENZO[D]THIAZOLE-2-CARBOXALDEHYDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:114095-04-4 SDS

114095-04-4Relevant articles and documents

Discovery of novel Tricyclic full agonists for the G-protein-coupled niacin receptor 109A with minimized flushing in rats

Shen, Hong C.,Ding,Deng, Qiaolin,Wilsie, Larissa C.,Krsmanovic, Mihajlo L.,Taggart, Andrew K.,Carballo-Jane, Ester,Ren, Ning,Cai,Wu,Wu, Kenneth K.,Cheng, Kang,Chen, Qing,Wolff, Michael S.,Tong, Xinchun,Holt, Tom G.,Waters, M. Gerard,Hammond, Milton L.,Tata, James R.,Colletti, Steven L.

supporting information; experimental part, p. 2587 - 2602 (2010/01/15)

Tricyclic analogues were rationally designed as the high affinity niacin receptor G-protein-coupled receptor 109A (GPR109A) agonists by overlapping three lead structures. Various tricyclic anthranilide and cycloalkene carboxylic acid full agonists were di

Structure-activity relationship of 6-methylidene penems bearing tricyclic heterocycles as broad-spectrum β-lactamase inhibitors: Crystallographic structures show unexpected binding of 1,4-thiazepine intermediates

Venkatesan, Aranapakam M.,Gu, Yansong,Santos, Osvaldo Dos,Abe, Takao,Agarwal, Atul,Yang, Youjun,Petersen, Peter J.,Weiss, William J.,Mansour, Tarek S.,Nukaga, Michiyoshi,Hujer, Andrea M.,Bonomo, Robert A.,Knox, James R.

, p. 6556 - 6568 (2007/10/03)

The design and synthesis of a series of seven tricyclic 6-methylidene penems as novel class A and C serine β-lactamase inhibitors is described. These compounds proved to be very potent inhibitors of the TEM-1 and AmpC β-lactamases and less so against the class B metallo-β-lactamase CcrA. In combination with piperacillin, their in vitro activities enhanced susceptibility of all class C resistant strains from various bacteria. Crystallographic structures of a serine-bound reaction intermediate of 17 with the class A SHV-1 and class C GC1 enzymes have been established to resolutions of 2.0 and 1.4 A?, respectively, and refined to R-factors equal 0.163 and 0.145. In both β-lactamases, a seven-membered 1,4-thiazepine ring has formed. The stereogenic C7 atom in the ring has the R configuration in the SHV-1 intermediate and has both R and S configurations in the GC1 intermediate. Hydrophobic stacking interactions between the tricyclic C7 substituent and a tyrosine side chain, rather than electrostatic or hydrogen bonding by the C3 carboxylic acid group, dominate in both complexes. The formation of the 1,4- thiazepine ring structures is proposed based on a 7-endo-trig cyclization.

HETEROTRICYCLYL 6-ALKYLIDENE-PENEMS AS ΒΕΤΑ-LACTAMASE INHIBITORS

-

Page/Page column 96, (2008/06/13)

The present invention provides a compound of formula I, pharmaceutical compositions and the use thereof for the treatment of bacterial infection or disease in a patient in need thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 114095-04-4